Phase 3 Cisplatin Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca150 enrolled59 locationsNCT06960577
Recruiting
Phase 3
Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial
Cisplatin-related Hearing Loss
The Netherlands Cancer Institute100 enrolled5 locationsNCT07281508
Recruiting
Phase 3
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
CisplatinCarboplatinNPC
Nanfang Hospital, Southern Medical University482 enrolled1 locationNCT03919552